CUV 1.58% $14.82 clinuvel pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-2

  1. 801 Posts.
    lightbulb Created with Sketch. 1050
    43% increase in revenue year on year not too bad considering US sales haven't started yet and there will still be more growth to come from Europe as more countries come online. The big revenue (and VERY profitable) quarters are still to come, 4 out of the next 7 quarters are the biggies.

    The shorters treat this company like it is going broke, it is not, it is very profitable and with US sales to start later this year it will become extremely profitable. What will the shorts do with all that growth to come? 22nd most shorted company what a joke, they are trying to sow fear when they should be fearful.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.82
Change
0.230(1.58%)
Mkt cap ! $739.1M
Open High Low Value Volume
$14.76 $14.96 $14.46 $969.3K 65.84K

Buyers (Bids)

No. Vol. Price($)
1 1 $14.82
 

Sellers (Offers)

Price($) Vol. No.
$14.83 209 14
View Market Depth
Last trade - 15.33pm 31/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.